These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 19633007)

  • 21. Forced expiratory volume in one second: not just a lung function test but a marker of premature death from all causes.
    Young RP; Hopkins R; Eaton TE
    Eur Respir J; 2007 Oct; 30(4):616-22. PubMed ID: 17906084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The value of forced expiratory volume in 1 second decline in the assessment of chronic obstructive pulmonary disease progression.
    Wise RA
    Am J Med; 2006 Oct; 119(10 Suppl 1):4-11. PubMed ID: 16996894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statin use is associated with reduced mortality in COPD.
    Søyseth V; Brekke PH; Smith P; Omland T
    Eur Respir J; 2007 Feb; 29(2):279-83. PubMed ID: 17050558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statins and cardiovascular risk reduction in patients with chronic kidney disease and end-stage renal failure.
    Baber U; Toto RD; de Lemos JA
    Am Heart J; 2007 Apr; 153(4):471-7. PubMed ID: 17383281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toward immunomodulatory and anti-inflammatory properties of statins.
    Arnaud C; Braunersreuther V; Mach F
    Trends Cardiovasc Med; 2005 Aug; 15(6):202-6. PubMed ID: 16182129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic manifestations and comorbidities of COPD.
    Barnes PJ; Celli BR
    Eur Respir J; 2009 May; 33(5):1165-85. PubMed ID: 19407051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use over time of statins in coronary patients in an Italian tertiary referral center.
    Gaspardone A; Proietti I; Altamura L; Tomai F; Versaci F; Crea F; Chiariello L; Gioffrè PA
    Ital Heart J; 2001 Nov; 2(11):848-53. PubMed ID: 11770871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic obstructive pulmonary disease and hospitalizations for pneumonia in a US cohort.
    Mannino DM; Davis KJ; Kiri VA
    Respir Med; 2009 Feb; 103(2):224-9. PubMed ID: 18945605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does lobectomy for lung cancer in patients with chronic obstructive pulmonary disease affect lung function? A multicenter national study.
    Baldi S; Ruffini E; Harari S; Roviaro GC; Nosotti M; Bellaviti N; Venuta F; Diso D; Rea F; Schiraldi C; Durigato A; Pavanello M; Carretta A; Zannini P
    J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1616-22. PubMed ID: 16308007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease.
    Sin DD; Man SF
    Can J Physiol Pharmacol; 2005 Jan; 83(1):8-13. PubMed ID: 15759045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chronic respiratory diseases and atherosclerosis].
    Teramoto S; Akashi S
    Nihon Rinsho; 2011 Jan; 69(1):158-62. PubMed ID: 21226277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does physical inactivity cause chronic obstructive pulmonary disease?
    Hopkinson NS; Polkey MI
    Clin Sci (Lond); 2010 Feb; 118(9):565-72. PubMed ID: 20132099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic obstructive pulmonary disease: a concise review.
    Balkissoon R; Lommatzsch S; Carolan B; Make B
    Med Clin North Am; 2011 Nov; 95(6):1125-41. PubMed ID: 22032431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Chronic obstructive pulmonary disease and cardiovascular diseases].
    Passowicz-Muszyńska E; Gostkowska-Malec A; Jankowska R; Piesiak P
    Pneumonol Alergol Pol; 2010; 78(1):28-32. PubMed ID: 20162516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular disease in chronic obstructive pulmonary disease.
    Hunninghake DB
    Proc Am Thorac Soc; 2005; 2(1):44-9. PubMed ID: 16113468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased cardiovascular risk in patients with chronic obstructive pulmonary disease and the potential mechanisms linking the two conditions: a review.
    Ghoorah K; De Soyza A; Kunadian V
    Cardiol Rev; 2013; 21(4):196-202. PubMed ID: 23095685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statin Effects on Exacerbation Rates, Mortality, and Inflammatory Markers in Patients with Chronic Obstructive Pulmonary Disease: A Review of Prospective Studies.
    Howard ML; Vincent AH
    Pharmacotherapy; 2016 May; 36(5):536-47. PubMed ID: 26990316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COPD and co-morbidities, with special emphasis on cardiovascular conditions.
    Löfdahl CG
    Clin Respir J; 2008 Oct; 2 Suppl 1():59-63. PubMed ID: 20298351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Complexity in chronic obstructive pulmonary disease. Individualized treatment, new approaches, phenotypes and comorbidities].
    Martín-Escudero JC
    Rev Clin Esp; 2011 Mar; 211 Suppl 2():13-21. PubMed ID: 21596169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of COPD: the sooner the better?
    Decramer M; Cooper CB
    Thorax; 2010 Sep; 65(9):837-41. PubMed ID: 20805184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.